When drugs to kill microbes are ineffective, host-directed therapy uses the body's own immune system to deal with the infection. This approach is being tested in patients with COVID-19, and now a team of researchers has published a study showing how it might also work in the fight against tuberculosis (TB).
from Latest Science News -- ScienceDaily https://ift.tt/3jAhml6
Related Posts :
Lava flows tell 600-year story of biodiversity loss on a tropical islandA natural experiment created by an active volcano gives new insight into the long-term negative impacts of human colonization of tropical fo… ...
Quadrupling turbines, US can meet 2030 wind-energy goalsThe United States could generate 20% of its electricity from wind within 10 years, without requiring any additional land, according to new r… ...
New tool for an old disease: Use of PET and CT scans may help develop shorter TB treatmentExperts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the d… ...
Anonymous no more: combining genetics with genealogy to identify the dead in unmarked gravesA method developed by a team of geneticists, archaeologists and demographers may make it possible to identify thousands of individuals whose… ...
The combination of plant-based particles and water forms an 'eco' super-gluePlant-based cellulose nanocrystals have remarkable inherent properties, and when combined with water, a powerful adhesive is formed that com… ...
0 Response to "Driving immunometabolism to control lung infection"
Post a Comment